Søgning


Flere søgeindstillinger

Søgning på udtrykket 'vaccination' giver 53 resultater


Dokumenter [10] Sider [2] Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [10]

Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab

Rekommandationer for profylakse og vaccination ved aspleni. Denne vejledning dækker anbefalinger omhandlende vaccinationer, antibiotika profylakse og patientinformation om generelle forholdsregler for at beskytte personer med aspleni mod infektioner. Version 1.2, 22.10.2024. Ændringer siden version 1.1: Vaccination mod Haemophilus influenzae ændret til 1 dosis (fejlagtigt angivet 3 doser). Menveo beskytter efter 1 dosis (fejlagtigt angivet som nødvendigt med 2.

Version 1, oktober 2024. Denne guideline omfatter konkret håndtering af mistænkte og bekræftede tilfælde af mpox med det formål at diagnosticere mpox, behandle tilfældet samt forebygge smittespredning samt forholdsregler ifm. vaccination mod infektionen.

Om håndtering og opfølgning for at minimere risiko for smitte med bl.a. HIV, HBV og HCV.

Denne vejledning er tiltænkt behandling af CVID hos voksne patienter. Den aktuelle udgave er opdateret med anvendelse af PCV20.

Denne vejledning er tiltænkt diagnostik og kontrol af CVID hos voksne patienter. Den aktulle udgave er opdateret med PCV20.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.

Udarbejdet af Dansk Selskab for Infektionsmedicin i samarbejde med Dansk Selskab for Klinisk Mikrobiologi, Dansk Hæmatologisk Selskab, Dansk Pædiatrisk Selskab, Dansk Selskab for Almen Medicin, Dansk Lungemedicinsk Selskab, Dansk Selskab for Obstetrik og Gynækologi, Dansk Transplantationsselskab, Dansk Selskab for Klinisk Onkologi, Statens Serum Institut & Fagligt Selskab for Hygiejnesygeplejersker

Bl.a. om primær og sekundær immundefekt, vaccinationer og visioner for specialet

Bilag til Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)

Sider [2]

…ndling, CVID udredning og opfølgning, Sekundær immundefekt: Søren Jensen-Fangel (tovholder), Christian Philip Fischer, Marie Helleberg, Jannik Helweg-Larsen, Lykke Larsen, Daria Podlekareva, Line Dahlerup Rasmussen, Pernille Ravn Aspleni, Vaccination af voksne kandidater og recipienter til solid organtransplantation, TNF-alfa screening: Pernille Ravn (tovholder) og Jan Gerstoft Screening, profylakse og information før behandling med anti-TNF-alfa (2011), Tjekliste ved screeni.

…e af splenektomi samt kongenit eller funktionel aspleni. Alvorlige infektioner skyldes primært Streptococcus pneumoniae, Haemophilus influenzae og Neisseria meningitidis. Risikoen for svær infektion ved malaria og dyrebid er også markant forhøjet. Vaccination, antibiotika profylakse/tidlig behandling og adækvat patient information er afgørende for forebyggelse af infektioner.


Kalender [1]
12. maj, Statens Serum Institut
Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

Proceedings of the National Academy of Sciences: Immunology and Inflammation
8.05.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 19, May 2025. SignificanceThe yellow fever vaccine is one of the most successful vaccines available. After a single dose, it induces long-lasting protective immunity against yellow fever, a severe disease caused by the yellow fever virus which is transmitted by .
PLoS One Infectious Diseases
7.05.2025
…n Animut Metkie, Yordanos Sisay Asgedom, Seblewongel Gebretsadik Sertsewold, Mesfin Abebe, Amanuel Yosef Gebrekidan, Tsion Mulat Tebeje . Background Infectious diseases that have affected countless newborns, children, and adults can be avoided with polio vaccination. The WHO and Lesotho’s health strategy placed a strong emphasis on vaccination as a means of preventing and controlling infectious diseases.
Journal of the American Medical Association
7.05.2025
This study examines respiratory syncytial virus (RSV) genomic surveillance results from 2 large US networks after the introduction of RSV vaccines.
Clinical Microbiology and Infection
7.05.2025
We recently read a study published by Kildegaard et al.[1], which evaluated the safety and efficacy of Tdap vaccination during pregnancy based on the Danish nationwide registry data system. Despite the rigorous design of the study, there are still several limitations. Firstly, the study period (2019-2023) spanned the outbreak and prevention period of the COVID-19 pandemic. During the pandemic, people's awareness of hygiene and protection increased, and social distancing measures reduced exposure risks.
Lancet Infectious Diseases
6.05.2025
These real-world estimates for the 2024 RSV season in Argentina show high RSVpreF effectiveness against RSV-associated LRTD and severe LRTD leading to hospitalisation from birth to age 3 months and sustained to age 6 months.
Malaria Journal
6.05.2025
. Background. Malaria is a major public health problem in Nigeria. This study set out to ascertain Nigerian nurses' knowledge and willingness to recommend malaria vaccination to caregivers of under-5 children. . Methods. This was a cross-sectional study carried out among nurses from all six geopolitical zones of Nigeria.
BMC Infectious Diseases
5.05.2025
. Background. Determining vaccination status among the population is key for vaccine research and surveillance. This study aimed to validate the combined use of Ontario Health Insurance Program (OHIP) physician billing claims and Ontario Drug Benefit program (ODB) pharmacist billing claims against data from the Canadian Community Health Survey (CCHS). . Methods.
BMJ Open
3.05.2025
. Objectives. There is a lack of information about household factors associated with delayed measles, mumps and rubella (MMR) vaccination. We examined whether timeliness of first MMR (MMR1) receipt is associated with sharing a household with an older child with non-receipt of MMR1 independent of household composition and size. . Design. Longitudinal observational study using linked electronic health records. . Setting. North East London, UK. . Participants.
Infection and Immunity
2.05.2025
Infection and Immunity, Ahead of Print.
BMC Infectious Diseases
1.05.2025
. Background. Human papillomavirus (HPV)-associated cancers are vaccine preventable. In 2016, the previously recommended three-dose HPV vaccination series was changed to a two-dose series and nine-valent HPV vaccine (9vHPV) became the only HPV vaccine available in the United States. Data on longer-term duration of antibodies following a 9vHPV two-dose series are limited.
JAMA Network Open New Online
30.04.2025
This cohort study compares changes in menstrual cycle length among individuals with regular prevaccination menstrual cycles who received influenza vaccination alone or concurrently with COVID-19 vaccination.
PLoS One Infectious Diseases
29.04.2025
…ević . Cervical cancer is a significant public health concern in Serbia, with high morbidity and mortality rates (27 and 14.2 per 100,000 women, respectively in 2020). The primary cause of cervical cancer is human papillomavirus (HPV) infection, and HPV vaccination has proven to be an effective prevention strategy.
BMC Infectious Diseases
26.04.2025
. Background. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination in solid organ transplant (SOT) recipients is associated with suboptimal antibody response (AbR) favouring breakthrough infection (BI). The role of cell-mediated immunity (CMI) remains uncertain. . Methods.
BMC Infectious Diseases
23.04.2025
…ised. Most of the vaccine-related side effects are mild. However, serious complications like anaphylaxis and thromboembolic events have also been reported. Various hematological disorders, including hypereosinophilia, have been reported following COVID-19 vaccination, the exact mechanisms of which remain unclear. . Case presentation.
PLoS One Infectious Diseases
23.04.2025
by Ryan Murphy, Lauren Pomerantz, Prabhani Kuruppumullage Don, Jun Sung Kim, Bradley A. Long .
PLoS One Infectious Diseases
17.04.2025
…egan Valerian Massawe, Godfrey Michael Orotta, Ashabilan Ebrahim, Eka Patricia Kisali, Stanley Kajaja, Brendan Shayo, Amunga Meda . Background Healthcare workers (HCWs) are at an increased risk of contracting and transmitting the hepatitis B virus (HBV). Vaccination coverage against HBV a cost- effective prevention, remains low among HCWs in some settings.
International Journal of Infectious Diseases
16.04.2025
TB remains the leading infectious cause of morbidity and mortality among children worldwide. In 2022, an estimated 214,000 children and adolescents under 15 years of age died from TB, with 139,000 deaths occurring among children under 5 years of age, as reported in the Global Tuberculosis Report 2023 [1]. Tens of millions of children are exposed to M. tuberculosis every year [2,3].
International Journal of Infectious Diseases
15.04.2025
…tion (WHO), global coverage for the first dose of the measles vaccine remained at 85% in 2023, while coverage for the second dose increased to 73%.[3,4] Despite three decades of substantial progress in reducing the global measles burden, some countries, particularly those in economically disadvantaged regions, continue to report rising cases and localized outbreaks.[3,4] Historical disparities in vaccination coverage may have significantly contributed to variations in the measles burden across regions.[5,6]
Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

Medscape Infectious Diseases
7.05.2025
The administration of influenza and COVID-19 vaccines leads to small changes in the length of the menstrual cycle, particularly when administering during the follicular phase. . Medscape News UK
Eurosurveillance latest updates
26.04.2025
… month) than those from higher-income families. The 2019 cohort did not reach the 95% WHO target of two MMR doses at 24 months of age, nor at 48 months. . . Discussion. With measles intensifying worldwide, these vaccination delays and inequalities may contribute to the resurgence of epidemics. In addition to vaccination mandates, an ambitious public health policy is needed to reduce inequalities in access to vaccination and to improve parents’ vaccine acceptance through educational strategies. . . .
Statens Serum Institut
25.04.2025
Statens Serum Institut anbefaler ikke længere rutinemæssig anvendelse af tabletter mod malaria til rejsende til de fleste lande/områder i Sydøstasien og i Mellem- og Sydamerika. Og vaccination mod tuberkulose anbefales primært til børn op til 11-12-års-alderen.
Morbidity and Mortality Weekly Report (MMWR)
25.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Medscape Infectious Diseases
25.04.2025
(This April 23 story has been corrected to add a dropped word in the headline) . Reuters Health Information
ProMED
16.04.2025
. . . YELLOW FEVER - AFRICA (02): UGANDA (KALIRO) MASS VACCINATION. ************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Mon 14 Apr 2025 . Source: Nile Post [edited] . nilepost.co.ug/health/253511/kaliro-targets-50000-in-yellow-fever-vaccination-drive . . .
ProMED
11.04.2025
. . . CHOLERA, DIARRHEA & DYSENTERY UPDATE (34): ANGOLA, VACCINATION. **************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Thu 10 Apr 2025 . Source: Africa CDC [edited] . africacdc.org/news-item/africa-cdc-supports-angola-to-fight-cholera/?utm_source=chatgpt.com . . .
Medscape Infectious Diseases
3.04.2025
Low vaccination rates coupled with vanishing vaccine research and development will challenge ID experts. . Medscape Medical News
ProMED
2.04.2025
. . . CHOLERA, DIARRHEA & DYSENTERY UPDATE (28): ETHIOPIA (GAMBELA PEOPLES). FATAL, VACCINATION. ****************************************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Tue 1 Apr 2025 . Source: Addis Standard [edited] .
Statens Serum Institut
1.04.2025
Statens Serum Institut anbefaler ikke længere rutinemæssig anvendelse af tabletter mod malaria til rejsende til de fleste lande/områder i Sydøstasien og i Mellem- og Sydamerika. Og vaccination mod tuberkulose anbefales primært til børn op til 11-12-års-alderen.
Morbidity and Mortality Weekly Report (MMWR)
1.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ProMED
30.03.2025
. . . RABIES (34): MALAYSIA (SARAWAK) PET DOGS, NEW CASES, VACCINATION. ****************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Sat 29 Mar 2025 . Source: Malay Mail [abridged, edited] . www.malaymail.com/news/malaysia/2025/03/29/sarawak-records-11-new-rabies-cases-in-march-pet-owners-urged-to-vaccinate/171326 . . .
ProMED
29.03.2025
. . . RABIES (31): VIET NAM (DONG NAI) DOG AND CAT VACCINATION CAMPAIGN. *****************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Wed 26 Mar 2025 . Source: Tuoi Tre News [abridged, edited] . tuoitrenews.vn/news/society/20250326/vietnams-dong-nai-ramps-up-disease-control-after-fatal-rabies-cases/85528.html . . .
ProMED
29.03.2025
. . . RABIES (29): TAIWAN (PINGTUNG) FERRET-BADGER, VACCINATION. *********************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . [1] . Date: Mon 24 Mar 2025 . Source: Central News Agency (CNA) [in Chinese, machine trans.,. edited] . www.cna.com.tw/news/aloc/202503240115.aspx . . .
Medscape Infectious Diseases
28.03.2025
France said on Wednesday its poultry flocks will be allowed outdoors again after a lull in bird flu infections that the government attributed to a vaccination. . Reuters Health Information
ProMED
27.03.2025
. . . RABIES (27): TUNISIA (SILIANA) DOG, DONKEY, VACCINATION. *******************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Mon 24 Mar 2025 13:26 CET . Source: Jawhara FM [in Arabic, machine trans., edited] . tinyurl.com/kssprsmn . . . The veterinary services of the Regional Delegation for Agricultural.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
Medscape Infectious Diseases
19.03.2025
A meta-analysis found no significant link between vaccination exposure and rheumatoid arthritis risk, but short-term data suggest that vaccines may have a protective effect. . Medscape Medical News

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2025 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.2.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 1.015 s

Cookies og privatliv